M&A Deal Summary

Ajinomoto Acquires Ajinomoto Cambrooke

On November 9, 2017, Ajinomoto acquired life science company Ajinomoto Cambrooke from Galen Partners for 64M USD

Acquisition Highlights
  • This is Ajinomoto’s 2nd transaction in the Life Science sector.
  • This is Ajinomoto’s 5th largest (disclosed) transaction.
  • This is Ajinomoto’s 4th transaction in the United States.
  • This is Ajinomoto’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2017-11-09
Target Ajinomoto Cambrooke
Sector Life Science
Buyer(s) Ajinomoto
Sellers(s) Galen Partners
Deal Type Add-on Acquisition
Deal Value 64M USD

Target

Ajinomoto Cambrooke

Ayer, Massachusetts, United States
Ajinomoto Cambrooke, Inc. is a therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ajinomoto

Tokyo, Japan
Category Company
Founded 1909
Sector Food
Employees34,862
Revenue 1.44T JPY (2024)
DESCRIPTION

Ajinomoto is a manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. Ajinomoto was incorporated in 1909 and is based in Tokyo, Japan.

DEAL STATS #
Overall 7 of 8
Sector (Life Science) 2 of 3
Type (Add-on Acquisition) 4 of 5
State (Massachusetts) 1 of 1
Country (United States) 4 of 5
Year (2017) 1 of 1
Size (of disclosed) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-16 Örgen Gıda Sanayi ve Ticaret A.Ş.

Güzelbahçe, Turkey

Örgen Gıda Sanayi ve Ticaret A.Ş. is a food company. Örgen Gıda Sanayi ve Ticaret A.Ş. was established in 1981 and is headquartered in Güzelbahçe, Turkey.

Buy TL220M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-26 Ajinomoto Animal Nutrition Europe S.A.S.

Paris, France

Ajinomoto Animal Nutrition Europe selects and produces amino acids through fermentation processes. It proposes and combines them to create solutions that respond to the specific issues related to swine, poultry, ruminant, and fish farming.

Sell -

Seller(S) 1

SELLER

Galen Partners

Stamford, Connecticut, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1990
PE ASSETS 1.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Galen Partners is a private equity firm that targets investments in the healthcare industry. Areas within healthcare that Galen will consider include medical devices & technology, specialty pharmaceuticals, and information technology/services. Galen typically invests between $10 and $30 million per transaction in companies with a proprietary product or service that have attained revenues above $10 million. Prospective transactions include growth equity investments, complete buyouts, family business or other recapitalizations, going-private transactions, roll-overs of a portion of existing equity, and management buyouts. Galen Partners was formed in 1990 and is based in Stamford, Connecticut.

DEAL STATS #
Overall 22 of 26
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 19 of 22
State (Massachusetts) 2 of 3
Country (United States) 22 of 26
Year (2017) 2 of 2
Size (of disclosed) 10 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-28 Consensys Imaging Service

Cary, Illinois, United States

Consensys Imaging Service, Inc. is a provider for medical diagnostic imaging equipment. Consensys leverages its proprietary technologies and advanced technical capabilities to provide high quality, cost-efficient service solutions for its customers across multiple modalities and vendor platforms.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-19 SMP

Miami, Florida, United States

SMP is a specialty pharmacy that provides treatments for a variety of complex disease states. SMP has developed specific therapeutic expertise in fertility and rheumatoid arthritis, and has strong experience in dermatology, infectious disease, gastroenterology, osteoporosis, and oncology. SMP was founded in 2003 and is based in Miami, Florida.

Buy -
Mergr

Product

Company

Legal